Trials / Completed
CompletedNCT06169995
A Study of Remimazolam Tosilate for Sedation in the Upper Gastrointestinal Endoscopy
A Multi-center, Open-label，Single-arm Clinical Trial to Evaluate the Efficacy and Safety of Remimazolam Tosilate for Injection for Sedation in Upper Gastrointestinal Endoscopy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of Remimazolam Tosilate for Injection for sedation in Upper Gastrointestinal Endoscopy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remimazolam Tosilate | bolus dose: 5mg，IV supplemental dose: 2.5mg，IV |
Timeline
- Start date
- 2023-12-11
- Primary completion
- 2023-12-15
- Completion
- 2023-12-16
- First posted
- 2023-12-14
- Last updated
- 2023-12-29
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06169995. Inclusion in this directory is not an endorsement.